Nihon Kohden Corporation

Tokyo Stock Exchange 6849.T

Nihon Kohden Corporation Net Income Margin for the year ending March 31, 2024: 7.67%

Nihon Kohden Corporation Net Income Margin is 7.67% for the year ending March 31, 2024, a -7.39% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Nihon Kohden Corporation Net Income Margin for the year ending March 31, 2023 was 8.28%, a -27.51% change year over year.
Nihon Kohden Corporation Net Income Margin for the year ending March 31, 2022 was 11.42%, a 25.08% change year over year.
Nihon Kohden Corporation Net Income Margin for the year ending March 31, 2021 was 9.13%, a 71.49% change year over year.
Nihon Kohden Corporation Net Income Margin for the year ending March 31, 2020 was 5.33%, a -14.90% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Tokyo Stock Exchange: 6849.T

Nihon Kohden Corporation

CEO	Mr. Hirokazu Ogino
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-31-4 Nishiochiai
Employees	5,891
Sector	Health Care
Industries Medical Instruments Hardware & Electronics Pharmaceuticals Telehealth

Description

Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years